Administration of a standard dose of vonoprazan fumarate delays gastric emptying in Japanese healthy adults: a prospective clinical trial

Background There is no established view of how gastric acid suppression affects the time for gastric emptying. Vonoprazan fumarate shows potent and durable gastric acid inhibitory effects, but its effects on gastric emptying have not been studied widely. We investigated the effects of vonoprazan fumarate on gastric emptying and measured serum gastrin and plasma ghrelin levels in healthy adults. Methods Ten participants were administered 10 mg vonoprazan fumarate daily for 14 days, then 20 mg vonoprazan fumarate daily for 14 days. The gastric emptying breath test was performed and serum gastrin levels were measured at baseline and after each medication administration period. The protocol was then repeated, with the gastric emptying breath test and serum gastrin and plasma desacyl-ghrelin levels measured at baseline and the end of the medication trial. Results Mean serum gastrin levels increased in a dose-dependent manner [baseline: 104.7 +/- 50.4, after 10 mg protocol: 328 +/- 123.8, after 20 mg protocol: 555 +/- 378.8 (pg/mL, mean +/- standard deviation), p = 0.0008]. There was a significant difference between the gastric emptying breath test Tmax at baseline and just after the 20 mg protocol (baseline: 45.5 +/- 15.3, after 20 mg protocol: 60.5 +/- 19.6 min, p = 0.0418). Plasma desacyl-ghrelin levels increased significantly just after the 20 mg protocol compared to those at baseline [baseline: 222.3 +/- 106.4, after 20 mg protocol: 366.2 +/- 178.6 (fmol/mL), p = 0.0008]. Conclusions In healthy adults, 14 days of vonoprazan fumarate administration at 20 mg/day delayed gastric emptying.

Automated summary

In healthy adults, 14 days of administration of vonoprazan fumarate at 20 mg/day delayed gastric emptying and significantly increased serum gastrin and plasma desacyl-ghrelin levels. These effects were dose-dependent.